Cardiol Therapeutics Inc Class A (CRDL.TO) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · Canada · ISIN CA14161Y2006
Cardiol Therapeutics Inc Class A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 CAD | 0.00 CAD |
| Gross profit | -373,114.00 CAD | -101,983.00 CAD |
| Operating income | -40.28 m CAD | -34.32 m CAD |
| EBIT | -36.68 m CAD | -34.32 m CAD |
| Net income | -36.68 m CAD | -33.82 m CAD |
| Diluted EPS – continuing operations | -0.51 CAD | -0.39 CAD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
More stocks
- Medinice S.A (ICE.WA)
- GEVORKYAN as (GEV.PR)
- Pine Cliff Energy Ltd (PNE.TO)
- Tai-Saw Technology Co Ltd (3221.TWO)
- Katahdin Bankshares Corp (KTHN)
- Maybank Securities (Thailand) PCL (MST.BK)
- RheinLand Holding AG (RLV.DU)
- GalaxiaMoneytree Co.Ltd (094480.KQ)
- Greenland Resources Inc (MOLY.NE)
- Bokusgruppen AB (BOKUS.ST)
- PPX Mining Corp (PPX.V)
- Chongkundang (001630.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.